Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-700-8 | CAS number: 2687-94-7 NOP; SURFADONE LP-100 SURFACTANT
Endpoint summary
Administrative data
Description of key information
The acute oral LD50 of N-(n-octyl)-2-pyrrolidinone is 2050 mg/kg bw. No other toxicity testing is undertaken.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 050 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Two acute oral toxicity tests were available in the ECHA migrated NONS file. In one the LD50 was found to be >2200 mg/kg bw in the other 2050 mg/kg bw. Neither result would trigger classification.
It is concluded that the acute oral LD50 for N-(n-octyl)-2 -pyrrolidinone is 2050 mg/kg bw, as this is the worst case scenario.
Two acute dermal toxicity tests were available in the ECHA migrated NONS files. In one, the LD50 is found to be >2000 mg/kg bw, and in the other it is found to be >4000 mg/kg bw. However, the second study is more reliable, following a clearly stated guideline in EU method B.3 and OECD 402, and being carried out in accordance with GLP standards, whereas the first study is carried out to GLP standards, but does not follow a specified guideline.
In conclusion, the lower acute dermal LD50 value of 2000 mg/kg bw is accepted as being the relevant endpoint, due to it being the worst case value found, in spite of it being taken from a less reliable study.
Justification for classification or non-classification
The acute oral LD50 of N-(n-octyl)-2-pyrrolidinone was found to be 2050 mg/kg bw, which is above the trigger value for any EU classification.
The acute dermal LD50 of N-(n-octyl)-2 -pyrrolidinone was found to be 2000 mg/kg bw, which is above the trigger for any EU classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
